{"id":236811,"date":"2025-05-23T10:35:40","date_gmt":"2025-05-23T10:35:40","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=236811"},"modified":"2025-05-23T10:35:40","modified_gmt":"2025-05-23T10:35:40","slug":"medicament-pentru-diabet-arma-neasteptata-in-lupta-impotriva-cancerului-de-prostata","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=236811","title":{"rendered":"Medicament pentru diabet, arm\u0103 nea\u015fteptat\u0103 \u00een lupta \u00eempotriva cancerului de prostat\u0103"},"content":{"rendered":"<p>\nDescoperirea a pornit de la o observa\u0163ie surprinz\u0103toare: pacien\u0163ii cu cancer de prostat\u0103 \u015fi diabet care luau medicamente ce vizeaz\u0103 proteina PPAR\u03b3 nu au prezentat recidive \u00een perioada urm\u0103ririi medicale, transmite Scitech Daily.<\/p>\n<p>\nStudiul retrospectiv a analizat 69 de pacien\u0163i cu cancer de prostat\u0103 \u015fi diabet de tip 2, urm\u0103ri\u0163i \u00eentre 2014-2023 de Universitatea Medical\u0103 din Innsbruck. Rezultatele au fost completate cu teste pe culturi celulare \u015fi experimente pe \u015foareci.<\/p>\n<p>\nPioglitazona nu doar c\u0103 a \u00eencetinit cre\u015fterea celulelor canceroase de prostat\u0103, dar le-a \u015fi modificat metabolismul, \u00eengreun\u00e2nd supravie\u0163uirea \u015fi r\u0103sp\u00e2ndirea acestora. Medicamentul pare s\u0103 reprogrameze celulele canceroase prin activarea receptorului PPAR\u03b3, o protein\u0103 cunoscut\u0103 pentru rolul s\u0103u \u00een reglarea metabolismului \u015fi sensibilit\u0103\u0163ii la insulin\u0103.<\/p>\n<p>\n\u201ePentru prima dat\u0103, avem observa\u0163ii clinice care arat\u0103 c\u0103 pacien\u0163ii cu cancer de prostat\u0103 \u015fi diabet zaharat care au primit medicamente care vizeaz\u0103 aceast\u0103 protein\u0103 au r\u0103mas f\u0103r\u0103 recidive&#8221;, explic\u0103 profesorul Lukas Kenner, unul dintre autorii principali.<\/p>\n<p>\nCercet\u0103torii avertizeaz\u0103 \u00eens\u0103 c\u0103 sunt necesare studii clinice suplimentare pentru a confirma dac\u0103 tratamentul poate fi utilizat \u015fi la pacien\u0163ii cu cancer de prostat\u0103 care nu sufer\u0103 de diabet.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un medicament obi\u015fnuit pentru diabet, pioglitazona, s-ar putea dovedi o arm\u0103 nea\u015fteptat\u0103 \u00een lupta \u00eempotriva cancerului de prostat\u0103, arat\u0103 un studiu realizat de cercet\u0103tori de la Universitatea Ume\u00e5.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[56443,15493,32260],"class_list":["post-236811","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-cancer-de-prostata","tag-diabet","tag-medicament"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/236811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=236811"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/236811\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=236811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=236811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=236811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}